Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Andrés
Íñiguez Romo
Publications by the researcher in collaboration with Andrés Íñiguez Romo (8)
2022
2021
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2016
-
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553
2012
-
Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology
Revista Espanola de Cardiologia, Vol. 65, Núm. 2, pp. 125-130
2010
-
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation
Circulation, Vol. 122, Núm. 10, pp. 1017-1025